查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1450316

遗传性听力损失市场：现况分析与预测（2023-2030）

Hereditary Deafness Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

由于听力损失治疗方法的不断发展，遗传性听力损失市场预计将以约 5.1% 的稳定速度成长。例如，哈佛医学院的研究人员于2024 年1 月在中国復旦进行的一项研究显示，6 名1 岁至7 岁患有遗传性听力损失的儿童接受了基因治疗，这6 名患者中有5名接受了基因治疗。在预测期内，有几个因素正在推动市场成长，包括听力损失发生率的急剧增加、对遗传性听力损失的认识不断提高以及耳鼻喉科投资的增加。除此之外，遗传性听损治疗效率的加速带来了有效的治疗程序，也稳定地推动了遗传性听损市场的发展。

根据诊断类型，市场分为物理测试、分子遗传学测试等。由于遗传性听力损失诊断需求不断增加，2022年体检细分市场将在全球遗传性听力损失市场中占据最大占有率。身体检查对于识别外耳异常、中耳病变和其他可能导致遗传性听力损失的结构异常至关重要。此外，身体检查还可以评估整体健康状况，识别与特定基因突变相关的症状特征，并指导进一步的诊断测试。因此，在诊断类型中，体检领域在2022年占据了重要的市场占有率。

根据治疗类型，市场分为助听器、人工耳蜗等。由于产品创新和批准的增加，预计人工耳蜗细分市场将在预测期内占据重要占有率。例如，2023 年 12 月，人工耳蜗技术供应商 Advanced Bionics 的人工耳蜗声音处理器产品 Marvel CI 获得 FDA 批准，宣布扩大听力保健服务和患者治疗效果。人工耳蜗是一种电子设备，可以为无法从助听器中受益的重度至极重度听力损失的人提供声音的感觉。人工耳蜗由放置在耳后的外部处理器和透过手术植入皮下的内部组件组成。人工耳蜗可以显着改善许多患有严重听力损失的人的言语感知和沟通能力。因此，在预测期内，人工耳蜗类别预计将在治疗类型中表现出更高的复合年增长率。

为了更瞭解遗传性听力损失的市场介绍，市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、义大利、欧洲其他地区）、亚太地区（中国） 、日本、印度、亚太地区其他地区）及世界其他地区。由于遗传性听力损失病例的迅速增加、人们对遗传性听力损失的认识不断提高以及对引进创新耳鼻喉科治疗的投资不断增加，北美在 2022 年的当前情景中占据主导地位。例如，根据美国卫生与公众服务部的数据，美国每 1,000 名儿童中约有 2 至 3 名出生时一隻或双耳患有可检测到的听力损失。政府机构正在启动遗传性听力损失意识计划，以帮助该地区越来越多的听力损失患者。因此，2022年北美将占据很大的市场占有率。

目录

第一章 市场介绍

  • 市场定义
  • 主要目标
  • 利益相关者
  • 限制

第二章 研究方法或前提条件

  • 调查过程
  • 调查方法
  • 受访者简介

第三章市场总结

第 4 章执行摘要

第五章 COVID-19 对遗传性听力损失市场的影响

第六章 遗传性听损市场收入，2020-2030

第七章市场洞察：依诊断类型

  • 体检
  • 分子遗传学检测
  • 其他

第 8 章市场洞察：依治疗类型

  • 助听器
    • 耳背式助听器
    • ITE助听器
    • ITC助听器
    • 其他
  • 人工耳蜗
  • 其他

第9章市场洞察：依地区

  • 北美
    • 美国
    • 加拿大
    • 其他北美
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 世界其他地区

第10章遗传性听损市场动态

  • 市场驱动力
  • 市场课题
  • 影响分析

第十一章遗传性听损市场机会

第十二章遗传性听损市场趋势

第十三章需求面与供给面分析

  • 需求面分析
  • 供给侧分析

第十四章价值链分析

第15章 竞争场景

  • 竞争格局
    • 波特五力分析

第十六章公司简介

  • Cochlear Ltd.
  • Envoy Medical
  • Advanced Bionics AG and affiliates
  • Zhejiang Nuoerkang Neuroelectronics Technology Co., Ltd.
  • Oticon Medical A/S
  • Medtronic
  • Sonova
  • Audina Hearing Instruments, Inc.
  • RION Co., Ltd.
  • GN Store Nord A/S

第十七章 免责声明

简介目录
Product Code: UMHE212650

Hereditary deafness refers to hearing loss that is passed down through generations within a family due to genetic factors. It can be caused by mutations in various genes involved in the development or function of the auditory system. Depending on the specific genetic mutation, hereditary deafness can be present at birth or develop later in life. Innovations in treatment options, which may include hearing aids and cochlear implants are leading to the growth of the market. Several other factors, such as rising research & development activities, rising healthcare expenditure, rising regulatory support, and a surge in government collaborations & partnerships are leading drivers of hereditary deafness globally.

The Hereditary Deafness Market is expected to grow at a steady rate of around 5.1% owing to the rising therapeutic developments for treating deafness. For instance, in January 2024, a research conducted in Fudan, China with Harvard Medical School researchers treated six children between the ages of one to seven suffering from a type of inherited deafness through gene therapy, in which five of the six children showed signs of improved hearing. Several factors, including a surge in the incidence of hearing loss, increasing awareness regarding hereditary deafness, and increased investments in otolaryngology departments are driving the market's growth during the forecast period. Apart from this, accelerated treatment efficiency with hereditary deafness has resulted in effective treatment procedures which are also driving this market of hereditary deafness at a steady rate.

Based on the diagnosis type, the market is segmented into physical examination, molecular genetic testing, and others. The physical examination segment held the maximum share in the global market of hereditary deafness in 2022 owing to the rising demand for hereditary deafness diagnostics. Physical examinations are essential for identifying external ear anomalies, middle ear pathologies, and other structural abnormalities that may contribute to hereditary deafness. Additionally, physical examinations can help assess overall health status, identify syndromic features associated with certain genetic mutations, and guide further diagnostic investigations. Thus, among the diagnosis types, the physical examination segment held a significant market share in 2022.

Based on treatment type, the market is categorized into hearing aids, cochlear implants, and others. The cochlear implants segment is expected to hold a significant share of the market in the forecast period owing to the rising product innovations and approvals. For instance, in December 2023, Advanced Bionics, a provider of cochlear implant technology, received FDA approval and announced the expansion of its cochlear implant sound processor product, Marvel CI, and feature offerings to improve hearing care delivery and patient outcomes. Cochlear implants are electronic devices that can provide a sense of sound to individuals with severe to profound hearing loss who do not benefit from hearing aids. They consist of an external processor worn behind the ear and an internal component surgically implanted under the skin. Cochlear implants can significantly improve speech perception and communication abilities in many people with severe hearing loss. Thus, the cochlear implants category is expected to witness a higher CAGR amongst treatment types during the forecast period.

For a better understanding of the market adoption of hereditary deafness, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the surge in cases of hereditary deafness, rising awareness about hereditary deafness, and the rising number of investments in introducing innovative otolaryngology therapies. For instance, according to the U.S. Department of Health and Human Services, about 2 to 3 out of every 1,000 children in the U.S. are born with a detectable level of hearing loss in one or both ears. Government organizations are initiating hereditary deafness awareness programs for the sake of the growing deafness cases in the region. Thus, amongst regions, North America held a significant share of the market in 2022.

Some of the major players operating in the market include Cochlear Ltd; Envoy Medical; Advanced Bionics AG and affiliates; Zhejiang Nuoerkang Neuroelectronics Technology Co., Ltd.; Oticon Medical A/S; Medtronic; Sonova; Audina Hearing Instruments, Inc.; RION Co., Ltd.; GN Store Nord A/S.

TABLE OF CONTENTS

1. MARKET INTRODUCTION

  • 1.1.Market Definitions
  • 1.2.Main Objective
  • 1.3.Stakeholders
  • 1.4.Limitation

2. RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1.Research Process of the Hereditary Deafness Market
  • 2.2.Research Methodology of the Hereditary Deafness Market
  • 2.3.Respondent Profile

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. IMPACT OF COVID-19 ON THE HEREDITARY DEAFNESS MARKET

6. HEREDITARY DEAFNESS MARKET REVENUE (USD BN), 2020-2030F

7. MARKET INSIGHTS BY DIAGNOSIS TYPE

  • 7.1.Physical Examination
  • 7.2.Molecular Genetic Testing
  • 7.3.Others

8. MARKET INSIGHTS BY TREATMENT TYPE

  • 8.1.Hearing Aids
    • 8.1.1.Behind-The-Ear Hearing Aids
    • 8.1.2.In-The-Ear Hearing Aids
    • 8.1.3.In-The-Canal Hearing Aids
    • 8.1.4.Others
  • 8.2.Cochlear Implants
  • 8.3.Others

9. MARKET INSIGHTS BY REGION

  • 9.1.North America
    • 9.1.1.U.S.
    • 9.1.2.Canada
    • 9.1.3.Rest of North America
  • 9.2.Europe
    • 9.2.1.Germany
    • 9.2.2.U.K.
    • 9.2.3.France
    • 9.2.4.Italy
    • 9.2.5.Spain
    • 9.2.6.Rest of Europe
  • 9.3.Asia-Pacific
    • 9.3.1.China
    • 9.3.2.Japan
    • 9.3.3.India
    • 9.3.4.Rest of Asia-Pacific
  • 9.4.Rest of World

10. HEREDITARY DEAFNESS MARKET DYNAMICS

  • 10.1.Market Drivers
  • 10.2.Market Challenges
  • 10.3.Impact Analysis

11. HEREDITARY DEAFNESS MARKET OPPORTUNITIES

12. HEREDITARY DEAFNESS MARKET TRENDS

13. DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1.Demand Side Analysis
  • 13.2.Supply Side Analysis

14. VALUE CHAIN ANALYSIS

15. COMPETITIVE SCENARIO

  • 15.1.Competitive Landscape
    • 15.1.1.Porters Fiver Forces Analysis

16. COMPANY PROFILED

  • 16.1.Cochlear Ltd.
  • 16.2.Envoy Medical
  • 16.3.Advanced Bionics AG and affiliates
  • 16.4.Zhejiang Nuoerkang Neuroelectronics Technology Co., Ltd.
  • 16.5.Oticon Medical A/S
  • 16.6.Medtronic
  • 16.7.Sonova
  • 16.8.Audina Hearing Instruments, Inc.
  • 16.9.RION Co., Ltd.
  • 16.10.GN Store Nord A/S

17. DISCLAIMER